Company intelligence / Profile preview

Luxottica

Milan, Lombardy, Italy
Ownership
Private
Employees
~180000
Development stage
Other
01

Overview

Luxottica (now EssilorLuxottica) is the world’s largest eyewear company, active commercially worldwide with a growing footprint in med-tech, including clinical diagnostics, surgical care, and devices for vision correction and eye disease detection/treatment

Therapeutic areas
NeurologyOphthalmology
Modalities
Device
Industry
Medical Imaging
02

Partnerships

Google (Google Glass)Fashion luxury brands (Giorgio Armani, Chanel, Prada, etc. for licensed eyewear)clinical AI developersResearch consortiums in myopia management

Beyond the preview

Go deeper on Luxottica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luxottica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call